title: Next generation dengue vaccines: a review of candidates in preclinical development.
abstract: Dengue represents a major public health problem of growing global importance. In the absence of specific dengue therapeutics, strategies for disease control have increasingly focused on the development of dengue vaccines. While a licensed dengue vaccine is not yet available, several vaccine candidates are currently being evaluated in clinical trials and are described in detail in accompanying articles. In addition, there are a large variety of candidates in preclinical development, which are based on diverse technologies, ensuring a continued influx of innovation into the development pipeline. Potentially, some of the current preclinical candidates may become next generation dengue vaccines with superior product profiles. This review provides an overview of the various technological approaches to dengue vaccine development and specifically focuses on candidates in preclinical development.
authors.affiliation: Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland.
authors.forename: Julia
authors.initials: J
authors.lastname: Schmitz
authors.forename: John
authors.initials: J
authors.lastname: Roehrig
authors.forename: Alan
authors.initials: A
authors.lastname: Barrett
authors.forename: Joachim
authors.initials: J
authors.lastname: Hombach
mesh_terms: D000818:Animals; D003715:Dengue / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000235:genetics / Q000276:immunology*; D003716:Dengue Virus / Q000235:genetics / Q000276:immunology*; D055808:Drug Discovery / Q000639:trends; D006801:Humans
chemical_list: D053059:Dengue Vaccines